These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31234468)

  • 21. NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response.
    Wang B; Hasan MK; Alvarado E; Yuan H; Wu H; Chen WY
    Oncogene; 2011 Feb; 30(8):907-21. PubMed ID: 20956937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive metabolomics analysis of prostate cancer tissue in relation to tumor aggressiveness and TMPRSS2-ERG fusion status.
    Dudka I; Thysell E; Lundquist K; Antti H; Iglesias-Gato D; Flores-Morales A; Bergh A; Wikström P; Gröbner G
    BMC Cancer; 2020 May; 20(1):437. PubMed ID: 32423389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Air pollution particles hijack peroxidasin to disrupt immunosurveillance and promote lung cancer.
    Wang Z; Zhai Z; Chen C; Tian X; Xing Z; Xing P; Yang Y; Zhang J; Wang C; Dong L
    Elife; 2022 Apr; 11():. PubMed ID: 35437145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroxidasin is regulated by the epithelial-mesenchymal transition master transcription factor Snai1.
    Sitole BN; Mavri-Damelin D
    Gene; 2018 Mar; 646():195-202. PubMed ID: 29305973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic-based identification of multiple pathways underlying n-butylidenephthalide-induced apoptosis in LNCaP human prostate cancer cells.
    Pang CY; Chiu SC; Harn HJ; Zhai WJ; Lin SZ; Yang HH
    Food Chem Toxicol; 2013 Sep; 59():281-8. PubMed ID: 23770345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of brominated proteins in renal extracellular matrix: Potential interactions with peroxidasin.
    Ivanov SV; Rose KL; Colon S; Vanacore RM; Hudson BG; Bhave G; Voziyan P
    Biochem Biophys Res Commun; 2023 Nov; 681():152-156. PubMed ID: 37776746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate Cancer.
    Ren S; Shao Y; Zhao X; Hong CS; Wang F; Lu X; Li J; Ye G; Yan M; Zhuang Z; Xu C; Xu G; Sun Y
    Mol Cell Proteomics; 2016 Jan; 15(1):154-63. PubMed ID: 26545398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peroxidasin contributes to lung host defense by direct binding and killing of gram-negative bacteria.
    Shi R; Cao Z; Li H; Graw J; Zhang G; Thannickal VJ; Cheng G
    PLoS Pathog; 2018 May; 14(5):e1007026. PubMed ID: 29775486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative proteomics analysis of sodium selenite-induced apoptosis in human prostate cancer cells.
    Chen P; Wang L; Li N; Liu Q; Ni J
    Metallomics; 2013 May; 5(5):541-50. PubMed ID: 23589036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coatomer subunit beta 2 (COPB2), identified by label-free quantitative proteomics, regulates cell proliferation and apoptosis in human prostate carcinoma cells.
    Mi Y; Sun C; Wei B; Sun F; Guo Y; Hu Q; Ding W; Zhu L; Xia G
    Biochem Biophys Res Commun; 2018 Jan; 495(1):473-480. PubMed ID: 29129687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteomics analyses of prostate cancer cells reveal cellular pathways associated with androgen resistance.
    Höti N; Shah P; Hu Y; Yang S; Zhang H
    Proteomics; 2017 Mar; 17(6):. PubMed ID: 28116790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell metabolomics identify regulatory pathways and targets of magnoline against prostate cancer.
    Sun H; Zhang AH; Liu SB; Qiu S; Li XN; Zhang TL; Liu L; Wang XJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Dec; 1102-1103():143-151. PubMed ID: 30391728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biallelic Deletion of
    Kim HK; Ham KA; Lee SW; Choi HS; Kim HS; Kim HK; Shin HS; Seo KY; Cho Y; Nam KT; Kim IB; Joe YA
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.
    Qiu JX; Zhou ZW; He ZX; Zhao RJ; Zhang X; Yang L; Zhou SF; Mao ZF
    Drug Des Devel Ther; 2015; 9():349-417. PubMed ID: 25609920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of asporin reprograms cancer cells to acquire resistance to oxidative stress.
    Sasaki Y; Takagane K; Konno T; Itoh G; Kuriyama S; Yanagihara K; Yashiro M; Yamada S; Murakami S; Tanaka M
    Cancer Sci; 2021 Mar; 112(3):1251-1261. PubMed ID: 33393151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testosterone promotes DNA damage response under oxidative stress in prostate cancer cell lines.
    Ide H; Lu Y; Yu J; China T; Kumamoto T; Koseki T; Yamaguchi R; Muto S; Horie S
    Prostate; 2012 Sep; 72(13):1407-11. PubMed ID: 22290195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-talk of alpha tocopherol-associated protein and JNK controls the oxidative stress-induced apoptosis in prostate cancer cells.
    Zhu B; Li X; Zhang Y; Ye C; Wang Y; Cai S; Huang H; Cai Y; Yeh S; Huang Z; Chen R; Tao Y; Wen X
    Int J Cancer; 2013 May; 132(10):2270-82. PubMed ID: 23129185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PAGE4 promotes prostate cancer cells survive under oxidative stress through modulating MAPK/JNK/ERK pathway.
    Lv C; Fu S; Dong Q; Yu Z; Zhang G; Kong C; Fu C; Zeng Y
    J Exp Clin Cancer Res; 2019 Jan; 38(1):24. PubMed ID: 30658679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An examination of the regulatory mechanism of Pxdn mutation-induced eye disorders using microarray analysis.
    Yang Y; Xing Y; Liang C; Hu L; Xu F; Mei Q
    Int J Mol Med; 2016 Jun; 37(6):1449-56. PubMed ID: 27121343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype.
    Kumar B; Koul S; Khandrika L; Meacham RB; Koul HK
    Cancer Res; 2008 Mar; 68(6):1777-85. PubMed ID: 18339858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.